Jeremy S. Bordeaux

ORCID: 0000-0002-7010-7730
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cutaneous Melanoma Detection and Management
  • Nonmelanoma Skin Cancer Studies
  • Reconstructive Facial Surgery Techniques
  • Skin Protection and Aging
  • Cutaneous lymphoproliferative disorders research
  • Reconstructive Surgery and Microvascular Techniques
  • Cancer and Skin Lesions
  • Nail Diseases and Treatments
  • Polyomavirus and related diseases
  • Ear and Head Tumors
  • Sarcoma Diagnosis and Treatment
  • Melanoma and MAPK Pathways
  • Infectious Diseases and Mycology
  • Health Systems, Economic Evaluations, Quality of Life
  • Immunotherapy and Immune Responses
  • Dermatologic Treatments and Research
  • CAR-T cell therapy research
  • Allergic Rhinitis and Sensitization
  • Wound Healing and Treatments
  • Medical Malpractice and Liability Issues
  • Vascular Tumors and Angiosarcomas
  • Medicine and Dermatology Studies History
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Diversity and Career in Medicine

University Hospitals Cleveland Medical Center
2012-2025

Case Western Reserve University
2016-2025

University School
2016-2025

University Hospitals Seidman Cancer Center
2021-2025

Cancer Institute (WIA)
2021-2025

Cleveland Clinic
2021-2025

University Hospitals of Cleveland
2017-2024

Merck Institute for Science Education
2024

Case Comprehensive Cancer Center
2009-2024

Brown University
2023

BACKGROUND Dermatofibrosarcoma protuberans (DFSP) is a rare cutaneous sarcoma for which data on risk factors, incidence, and survival are limited. OBJECTIVE The authors sought to establish comprehensive report the incidence of from primary DFSP. METHODS used 18 registries Surveillance, Epidemiology, End Results Program 2000 2010. RESULTS Overall was 4.1 per million person-years steady over decade. Trunk most common anatomic site except in older men. Incidence among women 1.14 times higher...

10.1097/dss.0000000000000300 article EN Dermatologic Surgery 2016-01-01

10.1016/j.jaad.2016.06.006 article EN Journal of the American Academy of Dermatology 2016-07-29

Basal cell carcinoma (BCC) is the most common form of skin cancer in United States. Due to high frequency, BCC occurrences are not typically recorded, and annual rates incidence can only be estimated. Current estimated 2 million Americans affected annually, this continues rise. Exposure radiation, from either sunlight or previous medical therapy, a key player development. as aggressive other cancers because it less likely metastasize. However, surgery radiation prevalent treatment options,...

10.6004/jnccn.2023.0056 article EN Journal of the National Comprehensive Cancer Network 2023-11-01

The NCCN Guidelines for Merkel Cell Carcinoma (MCC) provide recommendations diagnostic workup, clinical stage, and treatment options patients. panel meets annually to discuss updates the guidelines based on comments from expert review members, institutional review, as well submissions within external organizations. These Insights focus introduction of a new page locally advanced disease in setting node negative status, entitled “Clinical N0 Disease, Locally Advanced MCC.” This algorithm...

10.6004/jnccn.2024.0002 article EN Journal of the National Comprehensive Cancer Network 2024-01-01

Dermatofibrosarcoma protuberans (DFSP) is a rare cutaneous soft tissue sarcoma and affects an estimated 1,500 people annually in the United States. DFSP frequently exhibits extensive local infiltration. Initial treatment through surgical excision, care should be taken to ensure that negative margins are achieved minimize recurrence. Although has reported high rate of recurrence, metastasis more uncommon. Fibrosarcomatous aggressive variant with increased risk for recurrence metastasis. If...

10.6004/jnccn.2025.0001 article EN Journal of the National Comprehensive Cancer Network 2025-01-01

Knowledge regarding differences in dermatologic care for patients with a broad range of conditions is limited.To elucidate nationwide use outpatient care.Retrospective analysis nationally representative data from the 2007 to 2015 Medical Expenditure Panel Survey (MEPS) provided by Agency Healthcare Research and Quality. Health outcomes (skin cancers, infections, inflammatory conditions/ulcers, other skin disorders) were examined via multivariable logistic regression analyses office-based...

10.1001/jamadermatol.2018.3114 article EN JAMA Dermatology 2018-09-29

The NCCN Guidelines for Squamous Cell Skin Cancer provide recommendations diagnostic workup, clinical stage, and treatment options patients with cutaneous squamous cell carcinoma. panel meets annually to discuss updates the guidelines based on comments from members Institutional Review, as well submissions within external organizations. These Insights focus introduction of a new surgical recommendation terminology (peripheral deep en face margin assessment), recent topical prophylaxis,...

10.6004/jnccn.2021.0059 article EN Journal of the National Comprehensive Cancer Network 2021-12-01

10.1016/j.jaad.2016.07.046 article EN Journal of the American Academy of Dermatology 2016-10-10

Despite the clear potential benefits of neoadjuvant therapy, optimal regimen for patients with high-risk resectable melanoma (HRRM) is not known.

10.1001/jamaoncol.2023.7333 article EN cc-by JAMA Oncology 2024-03-28

Longer time from diagnosis to definitive surgery (TTDS) is associated with increased melanoma-specific mortality. Although black patients present later-stage melanoma and have worse survival than non-Hispanic white patients, the association between race TTDS unknown.To investigate racial differences in treatment.Retrospective review of National Cancer Database (2004-2015). Multivariable logistic regression was used evaluate TTDS, controlling for sociodemographic/disease characteristics.Of...

10.1016/j.jaad.2020.03.094 article EN other-oa Journal of the American Academy of Dermatology 2020-04-08
Coming Soon ...